Shenouda Maged (CIK 1658369) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Buy RLMD (120,200 shares), Buy RLMD (79,800 shares), Buy RLMD (11,665 shares), Buy RLMD (500,000 shares), Buy RLMD (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 120,200 | $504,840 |
| 2026-09-11 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 79,800 | $339,150 |
| 2025-12-16 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 11,665 | $48,060 |
| 2025-11-06 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 500,000 | $1.1M |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 50,000 | $22,000 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 90,000 | $44,100 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 60,000 | $31,200 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11